Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
46
pubmed:dateCreated
2005-11-15
pubmed:abstractText
Active NF-kappaB renders malignant hepatocytes refractory to the growth inhibitory and pro-apoptotic properties of transforming growth factorbeta1 (TGF-beta1). NF-kappaB counteracts TGF-beta1-induced apoptosis through up-regulation of downstream target genes, such as XIAP and Bcl-X(L), which in turn inhibit the intrinsic pathway of apoptosis. In addition, induction of NF-kappaB by TGF-beta1 inhibits JNK signaling, thereby attenuating TGF-beta1-induced cell death of normal hepatocytes. However, the mechanism involved in the negative cross-talk between the NF-kappaB and JNK pathways during TGF-beta1 signaling has not been determined. In this study, we have identified the XIAP gene as one of the critical mediators of NF-kappaB-mediated suppression of JNK signaling. We show that NF-kappaB plays a role in the up-regulation of XIAP gene expression in response to TGF-beta1 treatment and forms a TGF-beta1-inducible complex with TAK1. Furthermore, we show that the RING domain of XIAP mediates TAK1 polyubiquitination, which then targets this molecule for proteosomal degradation. Down-regulation of TAK1 protein expression inhibits TGF-beta1-mediated activation of JNK and apoptosis. Conversely, silencing of XIAP promotes persistent JNK activation and potentiates TGF-beta1-induced apoptosis. Collectively, our findings identify a novel mechanism for the regulation of JNK activity by NF-kappaB during TGF-beta1 signaling and raise the possibility that pharmacologic inhibition of the NF-kappaB/XIAP signaling pathway might selectively abolish the pro-oncogenic activity of TGF-beta1 in advanced hepatocellular carcinomas (HCCs) without affecting the pro-apoptotic effects of TGF-beta1 involved in normal liver homeostasis.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anthracenes, http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Glutathione Transferase, http://linkedlifedata.com/resource/pubmed/chemical/Luciferases, http://linkedlifedata.com/resource/pubmed/chemical/MAP Kinase Kinase 4, http://linkedlifedata.com/resource/pubmed/chemical/MAP Kinase Kinase Kinases, http://linkedlifedata.com/resource/pubmed/chemical/MAP kinase kinase kinase 7, http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinase 8, http://linkedlifedata.com/resource/pubmed/chemical/NF-kappa B, http://linkedlifedata.com/resource/pubmed/chemical/Proteasome Endopeptidase Complex, http://linkedlifedata.com/resource/pubmed/chemical/TGFB1 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Tgfb1 protein, mouse, http://linkedlifedata.com/resource/pubmed/chemical/Tgfb1 protein, rat, http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factor AP-1, http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta, http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta1, http://linkedlifedata.com/resource/pubmed/chemical/Ubiquitin, http://linkedlifedata.com/resource/pubmed/chemical/X-Linked Inhibitor of Apoptosis..., http://linkedlifedata.com/resource/pubmed/chemical/anthra(1,9-cd)pyrazol-6(2H)-one, http://linkedlifedata.com/resource/pubmed/chemical/bcl-X Protein
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0021-9258
pubmed:author
pubmed:issnType
Print
pubmed:day
18
pubmed:volume
280
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
38599-608
pubmed:dateRevised
2011-11-2
pubmed:meshHeading
pubmed-meshheading:16157589-Animals, pubmed-meshheading:16157589-Anthracenes, pubmed-meshheading:16157589-Apoptosis, pubmed-meshheading:16157589-Carcinoma, Hepatocellular, pubmed-meshheading:16157589-Cell Death, pubmed-meshheading:16157589-Cells, Cultured, pubmed-meshheading:16157589-Dose-Response Relationship, Drug, pubmed-meshheading:16157589-Down-Regulation, pubmed-meshheading:16157589-Enzyme Activation, pubmed-meshheading:16157589-Enzyme Inhibitors, pubmed-meshheading:16157589-Gene Silencing, pubmed-meshheading:16157589-Glutathione Transferase, pubmed-meshheading:16157589-Hepatocytes, pubmed-meshheading:16157589-Humans, pubmed-meshheading:16157589-Immunoblotting, pubmed-meshheading:16157589-Luciferases, pubmed-meshheading:16157589-MAP Kinase Kinase 4, pubmed-meshheading:16157589-MAP Kinase Kinase Kinases, pubmed-meshheading:16157589-Male, pubmed-meshheading:16157589-Mice, pubmed-meshheading:16157589-Mitogen-Activated Protein Kinase 8, pubmed-meshheading:16157589-Models, Biological, pubmed-meshheading:16157589-NF-kappa B, pubmed-meshheading:16157589-Proteasome Endopeptidase Complex, pubmed-meshheading:16157589-Protein Binding, pubmed-meshheading:16157589-Protein Structure, Tertiary, pubmed-meshheading:16157589-Rats, pubmed-meshheading:16157589-Rats, Sprague-Dawley, pubmed-meshheading:16157589-Signal Transduction, pubmed-meshheading:16157589-Time Factors, pubmed-meshheading:16157589-Transcription Factor AP-1, pubmed-meshheading:16157589-Transfection, pubmed-meshheading:16157589-Transforming Growth Factor beta, pubmed-meshheading:16157589-Transforming Growth Factor beta1, pubmed-meshheading:16157589-Ubiquitin, pubmed-meshheading:16157589-Up-Regulation, pubmed-meshheading:16157589-X-Linked Inhibitor of Apoptosis Protein, pubmed-meshheading:16157589-bcl-X Protein
pubmed:year
2005
pubmed:articleTitle
X-linked inhibitor of apoptosis (XIAP) inhibits c-Jun N-terminal kinase 1 (JNK1) activation by transforming growth factor beta1 (TGF-beta1) through ubiquitin-mediated proteosomal degradation of the TGF-beta1-activated kinase 1 (TAK1).
pubmed:affiliation
Department of Pharmacology, University of Tennessee Cancer Institute (UTCI), University of Tennessee Health Science Center, College of Medicine, University of Tennessee, Memphis, Tennessee 38163, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural